Industry News

New publication details the characterization of novel scaffold proteins that can enable engineered exosomes with defined therapeutic properties

exosomes

Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the advance online publication of a new manuscript. The paper, entitled “A versatile platform for generating engineered extracellular ...

Read More »